DCF — ADVENTIST HEALTH BAKERSFIELD
Enterprise Value: $-671.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-671.6M
Enterprise Value
$-214.6M
PV of Cash Flows
$-456.9M
PV of Terminal Value
$-735.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $484.8M | $-40.7M | -8.0% | $-61.2M | $-55.6M |
| Year 2 | $499.4M | $-36.9M | -7.0% | $-58.0M | $-47.9M |
| Year 3 | $514.4M | $-32.8M | -6.0% | $-54.6M | $-41.0M |
| Year 4 | $529.8M | $-31.2M | -6.0% | $-53.6M | $-36.6M |
| Year 5 | $545.7M | $-30.7M | -6.0% | $-53.8M | $-33.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-671.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$470.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0888435596577815
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5